Comparison Chart Ovid Therapeutics Inc.

Stocks

OVID

US6904691010

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:23:43 2026-08-03 EDT			5-day change	1st Jan Change
2.315 ^USD	+4.28%		-3.62%	+38.96%

09:15am	Oppenheimer Adjusts Ovid Therapeutics Price Target to $9 From $7, Maintains Outperform Rating	MT
07-08	Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	OVID THERAPEUTICS INC.	Bio Therapeutic Drugs	+3.38%	-3.62%	+38.96%	+356.19%	-38.78%	414M